Ionis Pharmaceuticals

IONSNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$7.312 B

$44.00 +1.15%

Close of 7 Oct 2026

As of 7 Oct 2026, Ionis Pharmaceuticals (IONS) has a market capitalization of $7.31B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$943.7M

#1558 by revenue

Earnings

-$381.4M

Loss-making

Shares outstanding

166,184,322

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#39Praxis Precision MedicinesPRAX$7.82B
#40AbivaxABVX$7.70B
#41Ionis PharmaceuticalsIONS$7.31B
#42Amneal PharmaceuticalsAMRX$7.07B
#43Spyre TherapeuticsSYRE$7.06B

Insiders buying

All insider buying →

One open-market purchase by officers and directors of Ionis Pharmaceuticals, worth $1.06M. Grants and option exercises are excluded.

Michael R. Hayden$1.06M
20,000 shares at $52.94 on 30 Jul 2026 · filed 31 Jul 2026

What if Ionis Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.8T

$173,237.97

Per share 3,937× higher

Bitcoin $1.67T

$10,050.57

Per share 228× higher

Nvidia $5.77T

$34,694.51

Per share 789× higher

Or at a round number

$10.0B $20.0B $50.0B $100.0B

Where these numbers come from

Share counts and financials for Ionis Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 8 Oct 2026. Read the methodology.